
Join to view full profile
2351 E 22nd StCleveland, OH 44115
Phone+1 216-861-6200
Fax+1 216-363-7490
Dr. Koram is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationResidency, Pulmonary Disease and Critical Care Medicine, 2021 - 2027
University of Ghana Medical SchoolClass of 2024, MBCHB
HARVARD TH CHAN SCHOOL OF PUBLIC HEALTHMPH
Certifications & Licensure
OH State Medical License 2015 - 2028
WI State Medical License 2024 - 2027
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Evaluation of the Effectiveness of Additional Risk Minimisation Measures for Tofacitinib (Xeljanz) in Europe: A Prescriber Survey.Joanne Wu, Nana Koram, Kofi Asomaning, Lubna Merchant, Robert Massouh
Clinical Drug Investigation. 2024-12-01 - 20 citationsWorldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.David T. Rubin, Irene Modesto, Severine Vermeire, Silvio Danese, Siew C. Ng
Alimentary Pharmacology & Therapeutics. 2021-10-09 - 27 citationsTofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claim...Jeffrey R. Curtis, Miguel Regueiro, Huifeng Yun, Chinyu Su, Marco DiBonaventura
Inflammatory Bowel Diseases. 2021-08-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: